Atypically Protracted Course of Liver Involvement in Kawasaki Disease. Case Report and Literature Review
Authors:
- Pamela PagliaPPPamela Paglia
- Lucia NazzaroLNLucia Nazzaro
- Anna Giulia Elena De AnserisAAAnna Giulia Elena De Anseris
- Milena LettieriMLMilena Lettieri
- Rossella ColantuonoRCRossella Colantuono
- Maria Chiara RoccoMRMaria Chiara Rocco
- Maria Anna SianoMSMaria Anna Siano
- Nicola BiffaroNBNicola Biffaro
- Pietro VajroPVPietro Vajro
Open Access
- 1 July 2021
- journal article
- case report
- Published by MDPI AG in Pediatric Reports
- Vol. 13 (3) , 357-362
Abstract
Hypertransaminasemia in patients with Kawasaki disease (KD) is reported to be transient. Here, we describe a child with an atypically protracted course of liver tests abnormalities and review the inherent literature. The patient was hospitalized at age 7-months for isolated hypertransaminasemia detected during a classical KD diagnosed 3 months before, and persistent since then. KD clinical evolution had been favorable, with rapid response to acetylsalicylic acid and intravenous immunoglobulins. Liver enzymes however remained persistently elevated with a fluctuating pattern (ALT > AST levels; peak of AST 186 IU/L and ALT 240 IU/L). During follow-up, the main causes of liver dysfunction had to be excluded through appropriate and extensive laboratory investigations. Transaminases values become steadily normal only 7 months after the acute presentation of KD. Conclusions: Our report shows that an atypically protracted courses of KD-related hypertransaminasemia above the previously reported temporal limits should be taken into account during the stepwise diagnostic approach to the patient’s liver dysfunction. Insidious acetylsalycilic acid-hepatotoxicity warrants consideration in the differential diagnosis.Keywords
This publication has 21 references indexed in Scilit:
- Kawasaki disease and hepatobiliary involvement: report of two casesItalian Journal of Pediatrics, 2016
- The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysisInflammation Research, 2015
- Descriptive Epidemiology of Kawasaki Disease in Japan, 2011–2012: From the Results of the 22nd Nationwide SurveyJournal of Epidemiology, 2015
- Hepatobiliary risk factors for clinical outcome of Kawasaki disease in childrenBMC Pediatrics, 2014
- Clinical features of recurrent Kawasaki disease and its risk factorsEuropean Journal of Pediatrics, 2013
- Persistent hypertransaminasemia in asymptomatic children: A stepwise approachWorld Journal of Gastroenterology, 2013
- Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of ChildrenClinical Chemistry, 2012
- Evolution of Laboratory Values in Patients With Kawasaki DiseaseThe Pediatric Infectious Disease Journal, 2011
- Abnormal Liver Panel in Acute Kawasaki DiseaseThe Pediatric Infectious Disease Journal, 2011
- Nonsteroidal Anti-Inflammatory Drug–Induced HepatotoxicityClinics in Liver Disease, 2007